EdgarLookup

Lazard, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Lazard, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
7.4%
Profit Margin
Net income ÷ revenue
4.8%
Return on Assets
Net income ÷ assets
4.52x
Debt-to-Equity
Total liabilities ÷ equity
+1.5%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.19B Feb 23, 2026
FY2025 Dec 31, 2024 $3.14B Feb 23, 2026
FY2025 Dec 31, 2023 $2.59B Feb 23, 2026
FY2024 Dec 31, 2022 $2.86B Feb 24, 2025
FY2023 Dec 31, 2021 $3.27B Feb 23, 2024
FY2022 Dec 31, 2020 $2.65B Feb 23, 2023
FY2021 Dec 31, 2019 $2.67B Feb 28, 2022
FY2020 Dec 31, 2018 $2.88B Feb 26, 2021
FY2019 Dec 31, 2017 $2.70B Feb 25, 2020
FY2018 Dec 31, 2016 $2.38B Feb 26, 2019

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $236.83M Feb 23, 2026
FY2025 Dec 31, 2024 $279.91M Feb 23, 2026
FY2025 Dec 31, 2023 ($75.48M) Feb 23, 2026
FY2024 Dec 31, 2022 $357.52M Feb 24, 2025
FY2023 Dec 31, 2021 $528.06M Feb 23, 2024
FY2022 Dec 31, 2020 $402.46M Feb 23, 2023
FY2019 Dec 31, 2019 $76.98M Feb 25, 2020
FY2019 Sep 30, 2019 $46.70M Feb 25, 2020
FY2019 Jun 30, 2019 $65.78M Feb 25, 2020
FY2019 Mar 31, 2019 $97.04M Feb 25, 2020

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $327.60M Feb 23, 2026
FY2025 Dec 31, 2024 $386.47M Feb 23, 2026
FY2025 Dec 31, 2023 ($79.96M) Feb 23, 2026
FY2024 Dec 31, 2022 $516.85M Feb 24, 2025
FY2023 Dec 31, 2021 $723.85M Feb 23, 2024
FY2022 Dec 31, 2020 $502.14M Feb 23, 2023
FY2019 Dec 31, 2019 $118.98M Feb 25, 2020
FY2019 Sep 30, 2019 $52.37M Feb 25, 2020
FY2019 Jun 30, 2019 $101.69M Feb 25, 2020
FY2019 Mar 31, 2019 $119.66M Feb 25, 2020

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $519.33M Feb 23, 2026
FY2025 Dec 31, 2024 $742.83M Feb 23, 2026
FY2025 Dec 31, 2023 $164.66M Feb 23, 2026
FY2024 Dec 31, 2022 $833.98M Feb 24, 2025
FY2023 Dec 31, 2021 $866.08M Feb 23, 2024
FY2022 Dec 31, 2020 $575.93M Feb 23, 2023
FY2021 Dec 31, 2019 $677.95M Feb 28, 2022
FY2020 Dec 31, 2018 $699.04M Feb 26, 2021
FY2019 Dec 31, 2017 $1.03B Feb 25, 2020
FY2018 Dec 31, 2016 $632.60M Feb 26, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $31.95M Feb 23, 2026
FY2025 Dec 31, 2024 $45.50M Feb 23, 2026
FY2025 Dec 31, 2023 $28.30M Feb 23, 2026
FY2024 Dec 31, 2022 $49.51M Feb 24, 2025
FY2023 Dec 31, 2021 $39.70M Feb 23, 2024
FY2022 Dec 31, 2020 $64.29M Feb 23, 2023
FY2021 Dec 31, 2019 $42.76M Feb 28, 2022
FY2020 Dec 31, 2018 $49.59M Feb 26, 2021
FY2019 Dec 31, 2017 $27.67M Feb 25, 2020
FY2018 Dec 31, 2016 $38.75M Feb 26, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.94B Feb 23, 2026
FY2025 Dec 31, 2024 $4.79B Feb 23, 2026
FY2024 Dec 31, 2023 $4.64B Feb 24, 2025
FY2023 Dec 31, 2022 $5.85B Feb 23, 2024
FY2022 Dec 31, 2021 $7.15B Feb 23, 2023
FY2022 Dec 31, 2020 $5.97B Feb 23, 2023
FY2021 Dec 31, 2019 $5.64B Feb 28, 2022
FY2020 Dec 31, 2018 $5.00B Feb 26, 2021
FY2019 Dec 31, 2017 $4.93B Feb 25, 2020
FY2018 Dec 31, 2016 $4.56B Feb 26, 2019

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.95B Feb 23, 2026
FY2025 Dec 31, 2024 $4.03B Feb 23, 2026
FY2024 Dec 31, 2023 $4.07B Feb 24, 2025
FY2023 Dec 31, 2022 $4.59B Feb 23, 2024
FY2022 Dec 31, 2021 $5.49B Feb 23, 2023
FY2021 Dec 31, 2020 $4.97B Feb 28, 2022
FY2020 Dec 31, 2019 $4.96B Feb 26, 2021
FY2019 Dec 31, 2018 $4.03B Feb 25, 2020
FY2018 Dec 31, 2017 $3.67B Feb 26, 2019
FY2017 Dec 31, 2016 $3.26B Feb 27, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $873.66M Feb 23, 2026
FY2025 Dec 31, 2024 $636.24M Feb 23, 2026
FY2024 Dec 31, 2023 $423.76M Feb 24, 2025
FY2023 Dec 31, 2022 $556.46M Feb 23, 2024
FY2022 Dec 31, 2021 $975.22M Feb 23, 2023
FY2021 Dec 31, 2020 $911.77M Feb 28, 2022
FY2020 Dec 31, 2019 $609.99M Feb 26, 2021
FY2019 Dec 31, 2018 $916.85M Feb 25, 2020
FY2018 Dec 31, 2017 $1.20B Feb 26, 2019
FY2017 Dec 31, 2016 $1.24B Feb 27, 2018

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $395.26M Feb 23, 2026
FY2025 Dec 31, 2024 $393.58M Feb 23, 2026
FY2025 Dec 31, 2023 $394.90M Feb 23, 2026
FY2025 Dec 31, 2022 $377.24M Feb 23, 2026
FY2024 Dec 31, 2021 $379.42M Feb 24, 2025
FY2023 Dec 31, 2020 $383.86M Feb 23, 2024
FY2022 Dec 31, 2019 $371.77M Feb 23, 2023
FY2021 Dec 31, 2018 $371.56M Feb 28, 2022
FY2020 Dec 31, 2017 $385.29M Feb 26, 2021
FY2019 Dec 31, 2016 $373.12M Feb 25, 2020

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.49B Feb 23, 2026
FY2025 Dec 31, 2024 $1.47B Feb 23, 2026
FY2024 Dec 31, 2023 $1.40B Feb 24, 2025
FY2023 Dec 31, 2022 $1.68B Feb 23, 2024
FY2022 Dec 31, 2021 $1.56B Feb 23, 2023
FY2021 Dec 31, 2020 $1.30B Feb 28, 2022
FY2020 Dec 31, 2019 $1.19B Feb 26, 2021
FY2019 Dec 31, 2018 $1.20B Feb 25, 2020
FY2018 Dec 31, 2017 $1.08B Feb 26, 2019
FY2017 Dec 31, 2016 $1.13B Feb 27, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.47B Feb 23, 2026
FY2025 Dec 31, 2024 $1.31B Feb 23, 2026
FY2025 Dec 31, 2023 $971.32M Feb 23, 2026
FY2024 Dec 31, 2022 $1.23B Feb 24, 2025
FY2023 Dec 31, 2021 $1.47B Feb 23, 2024
FY2022 Dec 31, 2020 $1.39B Feb 23, 2023
FY2021 Dec 31, 2019 $1.23B Feb 28, 2022
FY2020 Dec 31, 2018 $1.25B Feb 26, 2021
FY2019 Dec 31, 2017 $1.48B Feb 25, 2020
FY2018 Dec 31, 2016 $1.16B Feb 26, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.69B Feb 23, 2026
FY2025 Dec 31, 2024 $1.69B Feb 23, 2026
FY2024 Dec 31, 2023 $1.69B Feb 24, 2025
FY2023 Dec 31, 2022 $1.69B Feb 23, 2024
FY2022 Dec 31, 2021 $1.69B Feb 23, 2023
FY2021 Dec 31, 2020 $1.68B Feb 28, 2022
FY2020 Dec 31, 2019 $1.68B Feb 26, 2021
FY2019 Dec 31, 2018 $1.43B Feb 25, 2020
FY2018 Dec 31, 2017 $1.19B Feb 26, 2019
FY2017 Dec 31, 2016 $1.19B Feb 27, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 2 Feb 23, 2026
FY2025 Dec 31, 2024 2 Feb 23, 2026
FY2025 Dec 31, 2023 0 Feb 23, 2026
FY2024 Dec 31, 2022 3 Feb 24, 2025
FY2023 Dec 31, 2021 4 Feb 23, 2024
FY2022 Dec 31, 2020 3 Feb 23, 2023
FY2019 Dec 31, 2019 0 Feb 25, 2020
FY2019 Sep 30, 2019 0 Feb 25, 2020
FY2019 Jun 30, 2019 0 Feb 25, 2020
FY2019 Mar 31, 2019 0 Feb 25, 2020

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 2 Feb 23, 2026
FY2025 Dec 31, 2024 2 Feb 23, 2026
FY2025 Dec 31, 2023 0 Feb 23, 2026
FY2024 Dec 31, 2022 3 Feb 24, 2025
FY2023 Dec 31, 2021 4 Feb 23, 2024
FY2022 Dec 31, 2020 3 Feb 23, 2023
FY2019 Dec 31, 2019 0 Feb 25, 2020
FY2019 Sep 30, 2019 0 Feb 25, 2020
FY2019 Jun 30, 2019 0 Feb 25, 2020
FY2019 Mar 31, 2019 0 Feb 25, 2020

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $186.58M Feb 23, 2026
FY2025 Dec 31, 2024 $179.02M Feb 23, 2026
FY2025 Dec 31, 2023 $173.08M Feb 23, 2026
FY2024 Dec 31, 2022 $181.88M Feb 24, 2025
FY2023 Dec 31, 2021 $195.94M Feb 23, 2024
FY2022 Dec 31, 2020 $196.60M Feb 23, 2023
FY2021 Dec 31, 2019 $254.92M Feb 28, 2022
FY2020 Dec 31, 2018 $359.64M Feb 26, 2021
FY2019 Dec 31, 2017 $341.45M Feb 25, 2020
FY2018 Dec 31, 2016 $336.14M Feb 26, 2019